InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP) plus 5-fluorouracil (5-FU) vs carboplatin (C) plus weekly paclitaxel (P) in patients (pts) with inoperable locally recurrent (ILR) or metastatic treatment naïve disease - An International Rare Cancers Initiative (IRCI) trial

S. Rao, F. Sclafani, C. Eng, M. Grønlie Guren, R. A. Adams, A. Benson, D. Sebag-Montefiore, E. Segelov, A. Bryant, C. Peckitt, A. Roy, M. T. Seymour, J. Welch, M. P. Saunders, R. Muirhead, J. Bridgewater, S. Falk, R. Glynne-Jones, D. Arnold, D. Cunningham

Research output: Contribution to journalArticlepeer-review

43 Scopus citations
Original languageEnglish (US)
Pages (from-to)viii715-viii716
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this